ClinChoice is a global, mid-size contract research organization (CRO) that specializes in clinical development, post-marketing, and functional service support for drugs and medical devices. Founded in 1995, the company focuses on accelerating the development and commercialization of innovative therapies to enhance health and safety worldwide.

The company provides comprehensive solutions throughout the product lifecycle, including clinical development, biometrics, drug safety, medical affairs, regulatory consulting, and real-world evidence generation. ClinChoice operates across various therapeutic specialties and sectors, such as pharmaceuticals, biotechnology, medical devices, and consumer health. With a strong global presence in over 20 countries, including the United States, China, and India, ClinChoice emphasizes a client-focused approach, ensuring high-quality outcomes delivered on time and within budget.

ClinChoice has expanded its capabilities through strategic mergers and acquisitions, enhancing its global footprint. The company is committed to fostering long-term partnerships and has implemented advanced systems to improve project management and regulatory compliance.